RCKT (STOCKS)
Rocket Pharmaceuticals, Inc. Common Stock
$2.811000
+0.061000 (+2.22%)
Prev close: $2.750000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Gaurav D. Shah
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $312.84M
- Employees
- 299
- P/E (TTM)
- -1.52
- P/B (TTM)
- 1.26
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
7
Buy
7
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.42 | $-0.42 | -0.0049 | -1.18% |
|
Dec 2025 (Q4)
|
$-0.38 | $-0.46 | +0.0824 | +17.82% |
|
Sep 2025 (Q3)
|
$-0.45 | $-0.52 | +0.0651 | +12.64% |
|
Jun 2025 (Q2)
|
$-0.59 | $-0.57 | -0.0222 | -3.91% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $215.87M |
| Research and Development | $137.53M |
| Other Operating Expenses | $78.34M |
| Operating Income/Loss | -$215.87M |
| Income/Loss From Continuing Operations After Tax | -$209.38M |
| Income/Loss From Continuing Operations Before Tax | -$209.38M |
| Interest Expense, Operating | $1.89M |
| Net Income/Loss | -$209.38M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$209.38M |
| Net Income/Loss Available To Common Stockholders, Basic | -$209.38M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.87 |
| Diluted Earnings Per Share | -$1.87 |
| Basic Average Shares | 334,948,451 |
| Diluted Average Shares | 334,948,451 |
| Assets | $285.41M |
| Current Assets | $149.83M |
| Cash | $144.40M |
| Other Current Assets | $5.43M |
| Noncurrent Assets | $135.58M |
| Fixed Assets | $26.66M |
| Intangible Assets | $25.15M |
| Other Non-current Assets | $83.78M |
| Liabilities | $47.37M |
| Current Liabilities | $24.47M |
| Wages | $5.24M |
| Other Current Liabilities | $19.23M |
| Noncurrent Liabilities | $22.90M |
| Equity | $238.04M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $238.04M |
| Liabilities And Equity | $285.41M |
| Net Cash Flow From Operating Activities | -$179.62M |
| Net Cash Flow From Operating Activities, Continuing | -$179.62M |
| Net Cash Flow From Investing Activities | $179.25M |
| Net Cash Flow From Investing Activities, Continuing | $179.25M |
| Net Cash Flow From Financing Activities | -$113.68M |
| Net Cash Flow From Financing Activities, Continuing | -$113.68M |
| Net Cash Flow | -$114.05M |
| Net Cash Flow, Continuing | -$114.05M |
| Comprehensive Income/Loss | -$209.39M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$209.47M |
| Other Comprehensive Income/Loss | -$140.47M |